Department of Biomedical Engineering, The University of Arizona, Tucson, AZ 85721, United States.
Department of Biomedical Engineering, The University of Arizona, Tucson, AZ 85721, United States.
Biosens Bioelectron. 2021 May 1;179:113099. doi: 10.1016/j.bios.2021.113099. Epub 2021 Feb 19.
The SARS-CoV-2 pandemic, an ongoing global health crisis, has revealed the need for new technologies that integrate the sensitivity and specificity of RT-PCR tests with a faster time-to-detection. Here, an emulsion loop-mediated isothermal amplification (eLAMP) platform was developed to allow for the compartmentalization of LAMP reactions, leading to faster changes in emulsion characteristics, and thus lowering time-to-detection. Within these droplets, ongoing LAMP reactions lead to adsorption of amplicons to the water-oil interface, causing a decrease in interfacial tension, resulting in smaller emulsion diameters. Changes in emulsion diameter allow for the monitoring of the reaction by use of angle-dependent light scatter (based off Mie scatter theory). Mie scatter simulations confirmed that light scatter intensity is diameter-dependent and smaller colloids have lower intensity values compared to larger colloids. Via spectrophotometers and fiber optic cables placed at 30° and 60°, light scatter intensity was monitored. Scatter intensities collected at 5 min, 30° could statistically differentiate 10, 10, and 10 copies/μL initial concentrations compared to NTC. Similarly, 5 min scatter intensities collected at 60° could statistically differentiate 10 copies/μL initial concentrations in comparison to NTC. The use of both angles during the eLAMP assay allows for distinction between high and low initial target concentrations. The efficacy of a smartphone-based platform was also tested and had a similar limit of detection and assay time of less than 10 min. Furthermore, fluorescence-labeled primers were used to validate target nucleic acid amplification. Compared to existing LAMP assays for SARS-CoV-2 detection, these times-to-detections are very rapid.
SARS-CoV-2 大流行是一场持续的全球健康危机,它揭示了人们对新技术的需求,这些技术需要将 RT-PCR 检测的灵敏度和特异性与更快的检测时间相结合。在这里,开发了一种乳液环介导等温扩增(eLAMP)平台,以允许 LAMP 反应的分区化,从而导致乳液特性更快地变化,从而降低检测时间。在这些液滴中,正在进行的 LAMP 反应导致扩增子被吸附到水油界面,导致界面张力降低,从而导致乳液直径减小。乳液直径的变化允许通过使用依赖角度的光散射(基于 Mie 散射理论)来监测反应。 Mie 散射模拟证实,光散射强度与直径有关,与较大的胶体相比,较小的胶体具有较低的强度值。通过放置在 30°和 60°的分光光度计和光纤电缆来监测光散射强度。在 5 分钟时收集的散射强度,可以在 30°处统计地区分 10、10 和 10 拷贝/μL 的初始浓度与 NTC。同样,在 60°处收集的 5 分钟散射强度可以在统计学上区分 10 拷贝/μL 的初始浓度与 NTC。在 eLAMP 测定中使用这两个角度可以区分高初始靶浓度和低初始靶浓度。还测试了基于智能手机的平台的功效,其检测限和测定时间也相似,均小于 10 分钟。此外,还使用荧光标记的引物来验证靶核酸的扩增。与现有的用于 SARS-CoV-2 检测的 LAMP 测定相比,这些检测时间非常快。